{"entity":{"type":"insider","cik":"0001801047","url":"/insider/0001801047","json_url":"/insider/0001801047.json","name":"Lock Kenneth A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":5,"first":"2021-03-03","last":"2023-03-08","span_basis":"filed_date"},"name_variants":[{"name":"Lock Kenneth A.","source":"filing","n_filings":5,"first_seen":"2021-03-03","last_seen":"2023-03-08"}],"transactions":[{"id":8748871,"accession":"0001567619-23-004667","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-23-004667","line_url":"/filing/0001567619-23-004667#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801047","owner_name":"Lock Kenneth A.","owner_display_name":"Lock Kenneth A.","owner_url":"/insider/0001801047","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":831.0,"shares_display":"831","price_per_share":15.2636,"price_display":"15.26","price_state":"stated","total_value":12684.0516,"total_display":"12,684.05","total_whole":"12,684","shares_owned_after":63429.0,"shares_owned_after_display":"63,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider"},{"id":8485541,"accession":"0001567619-23-004269","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-23-004269","line_url":"/filing/0001567619-23-004269","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801047","owner_name":"Lock Kenneth A.","owner_display_name":"Lock Kenneth A.","owner_url":"/insider/0001801047","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1432.0,"shares_display":"1,432","price_per_share":15.827021508379888,"price_display":"15.83","price_state":"stated","total_value":22664.2948,"total_display":"22,664.29","total_whole":"22,664","shares_owned_after":43278.0,"shares_owned_after_display":"43,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-02","scope":"insider","n_lines":2},{"id":8485531,"accession":"0001567619-23-004269","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-23-004269","line_url":"/filing/0001567619-23-004269#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801047","owner_name":"Lock Kenneth A.","owner_display_name":"Lock Kenneth A.","owner_url":"/insider/0001801047","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":936.0,"shares_display":"936","price_per_share":16.1663,"price_display":"16.17","price_state":"stated","total_value":15131.6568,"total_display":"15,131.66","total_whole":"15,132","shares_owned_after":44692.0,"shares_owned_after_display":"44,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-02","scope":"insider"},{"id":6355552,"accession":"0001567619-22-006495","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-22-006495","line_url":"/filing/0001567619-22-006495#line-3","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801047","owner_name":"Lock Kenneth A.","owner_display_name":"Lock Kenneth A.","owner_url":"/insider/0001801047","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30.0,"shares_display":"30","price_per_share":16.4449,"price_display":"16.44","price_state":"stated","total_value":493.347,"total_display":"493.35","total_whole":"493","shares_owned_after":44011.0,"shares_owned_after_display":"44,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-07","scope":"insider"},{"id":6355548,"accession":"0001567619-22-006495","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-006495","line_url":"/filing/0001567619-22-006495#line-2","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801047","owner_name":"Lock Kenneth A.","owner_display_name":"Lock Kenneth A.","owner_url":"/insider/0001801047","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":993.0,"shares_display":"993","price_per_share":16.8591,"price_display":"16.86","price_state":"stated","total_value":16741.0863,"total_display":"16,741.09","total_whole":"16,741","shares_owned_after":44041.0,"shares_owned_after_display":"44,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-04","filed_date":"2022-03-07","scope":"insider"},{"id":6979086,"accession":"0001567619-22-006226","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-006226","line_url":"/filing/0001567619-22-006226#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801047","owner_name":"Lock Kenneth A.","owner_display_name":"Lock Kenneth A.","owner_url":"/insider/0001801047","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":935.0,"shares_display":"935","price_per_share":17.7527,"price_display":"17.75","price_state":"stated","total_value":16598.7745,"total_display":"16,598.77","total_whole":"16,599","shares_owned_after":31734.0,"shares_owned_after_display":"31,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-03","scope":"insider"},{"id":5437047,"accession":"0001567619-21-005539","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-005539","line_url":"/filing/0001567619-21-005539#line-1","is_derivative":false,"issuer_cik":"0001787306","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001787306","owner_cik":"0001801047","owner_name":"Lock Kenneth A.","owner_display_name":"Lock Kenneth A.","owner_url":"/insider/0001801047","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":933.0,"shares_display":"933","price_per_share":34.1991,"price_display":"34.20","price_state":"stated","total_value":31907.7603,"total_display":"31,907.76","total_whole":"31,908","shares_owned_after":22167.0,"shares_owned_after_display":"22,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001787306","name":"Arcutis Biotherapeutics, Inc.","url":"/issuer/0001787306","role":"Officer (Chief Commercial Officer)","n_filings":5,"first_seen":"2021-03-03","last_seen":"2023-03-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001801047","retrieved_at":"2026-08-25T03:43:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}